NgCM109 Notes
NgCM109 Notes
BASIC
META-
BOLIC
PANEL
(BMP)
Glucose Glu 70-110 mg/
dL
Sodium Na 135-145
mE q/L
Potassium K 3.5-5 mEq/
L
Creatinine n/a 0.6-1.2 mg/
dL
Blood Urea BUN 10-20 mg/
Nitrogen dL
COOMB’S TEST
Indirect Coomb's Test
● Used in prenatal testing of pregnant
women and in testing blood prior to a
blood transfusion
● A negative indirect Coombs test for Rh
factor (Rh antibody titer) in a pregnant
woman means that she has not
developed antibodies against the Rh-
positive blood of her baby.
Fetal Ultrasound
● A test done during pregnancy that
uses reflected sound waves.
Cardiotocography or CTG :
● Monitor the fetal heartbeat and
contractions of the uterus, and provide
a continuous recording or baby's
heartbeat and contractions on a strip
of paper or on a computer.
Interpretation
interpretation of a CTG tracing requires both
qualitative and quantitative description of:
● Uterine activity (contractions)
● Baseline fetal heart rate (FHR)
● Baseline FHR variability
Fetal Deceleration
● Refer to temporary but distinct
decreases of the fetal heart rate (FHR)
identified during electronic fetal heart
monitoring.
● FHR baseline usually ranges from
120-160 beats per minute (bpm);
however, with fetal decelerations, the
heart rate usually drops about 40bpm
below baseline.
Amniocentesis
● Amniocentesis is a test that can be
done during pregnancy to look for birth
defects and genetic problems in the
developing baby.
● Amniocentesis removes a small
amount of fluid from the sac around
the baby in the womb (uterus). It is
most often done in a doctor's office or
medical center. You do not need to
stay in the hospital.
● 1. Aspiration of amniotic fluid; best
performed between 15 and 20 weeks
of pregnancy because amniotic fluid
volume is adequate and many viable
fetal cells are present in the and 20
weeks of pregnancy because amniotic
fluid volume is adequate and many
viable fetal cells are present in the fluid
by this time
● 2. Performed to determine genetic
disorders, metabolic defects, and fetal
lung maturity
Risks
● a. Maternal hemorrhage
● b. Infection
● c. Rh isoimmunization
● d. Abruptio placentae
● e. Amniotic fluid emboli
● f. Premature rupture of the
membranes
Interventions
● a. Obtain informed consent.
● b. If less than 20 weeks' gestation,
the client should have a full bladder to
support the uterus; if performed after
20 weeks' gestation, the client should
have an empty bladder to minimize
chance of puncture.
● c. Prepare the client for
ultrasonography, which is performed to
locate the placenta and avoid
puncture.
● d. Obtain baseline vital signs and fetal
heart rate; monitor every 15 minutes.
● e. Position the client supine during
the examination and on the left side
after the procedure.
● After chorionic villus sampling and
amniocentesis, instruct the client that
if chills, fever, bleeding, leakage of
fluid at the needle insertion site,
decreased fetal movement, uterine
contractions, or cramping occurs, she
must notify the physician or nurse
Embryoscopy
● Embryoscopy is the examination of the
embryo at 9-10 weeks' gestation
through the intact membranes by
introducing an endoscope into the
exocoelomic space transcervically or
transabdominally. This is likely to
remain confined to the management of
early pregnancy in selected families
affected by recurrent genetic
syndromes with recognizable external
fetal abnormalities. The procedure-
related risk of fetal loss is around 12
per cent.
Fetoscopy
● Fetoscopy is the examination of the
fetus after 11 weeks' gestation. This is
performed transabdominally in the
amniotic fluid. The technique has
evolved with the miniaturization of the
optical device by using fibre-optics
technology. This procedure is likely to
find new applications with the
development of ultrasound
examination at 10-14 weeks' gestation
in order to, either confirm, or rule out
suspected external fetal abnormalities.
Gestational Conditions
1. Hyperemesis Gravidarum
2. Ectopic pregnancy
3. Gestational Trophoblastic Disease
(H-mole)
4. Incompetent cervix
5. Spontaneous Abortion
6. Placenta Previa
7. Abruptio Placenta
8. Premature Rupture of Membranes
9. Pregnancy-induced Hypertension
Rheumatic fever
● is an inflammatory autoimmune
disease that affects the connective
tissues of the heart, joints,
subcutaneous tissues, and blood
vessels of the central nervous system.
● The most serious rheumatic heart
disease, which affects the cardiac
valves, particularly the mitral valve.
● Rheumatic fever manifests 2 to 6
weeks after an untreated or partially
treated group A beta-hemolytic
streptococcal infection of the upper
respiratory tract.
● Jones criteria are used to help
determine the diagnosis
CLASSIFICATION OF DM
SUBSTANCE ABUSE
Substance Abuse Pregnancy…
● "The fetus grows & develops d/t the
nourishment from the mother via the
placenta.
● Toxins in the mother's system may be
●
● Sexual transmission
– Happens when there is contact with
infected sexual fluids (rectal, genital,
or oral mucous membranes). This can
happen while having sex without a
condom, including vaginal, oral, and
anal sex, or sharing sex toys with
someone who is HIV-positive.
● Perinatal transmission
– A mother can transmit HIV to her child
during childbirth, pregnancy, and also
through breastfeeding.
● Blood transmission
– The risk of transmitting HIV through
blood transfusion is extremely low in
developed countries, thanks to
meticulous screening and precautions.
– However, among people who inject
drugs, sharing and reusing syringes
contaminated with HIV-infected blood
is extremely hazardous.
ELISA
● An enzyme-linked immunosorbent
assay, also called ELISA or EIA, is a
test that detects and measures
antibodies in your blood.
● This test can be used to determine if
you have antibodies related to certain
infectious conditions.
● An ELISA test may be used to
diagnose: HIV, which causes AIDS.
A. Description
. Testing detects HIV, which is the
cause of AIDS.
. Common tests used to determine the
presence of antibodies to HIV include
ELISA, Western blot, and
immunofluorescence assay (IFA).
. A single reactive ELISA test by itself
cannot be used to diagnose HIV and
should be repeated in duplicate with
the same blood sample; if the result is
repeatedly reactive, follow-up tests
using Western blot Or IFA should be
performed.
. A positive Western blot or IFA result
is considered confirmatory for HIV.
. A positive ELISA result that fails to be
confirmed by Western blot or IFA
should not be considered negative,
and repeat testing should take place in
3 to 6 months.
B. CD4- T-cell counts
1. Monitors the progression Of HIV
G. Oral testing for HIV
. Uses a device that is placed against
the gum and cheek for
2 minutes
. Fluid (not saliva) is drawn into an
absorbable pad, which, in an HIV-
positive individual, contains
antibodies.
. The pad is placed in a solution and a
specified observable change is noted if
the test result is positive.
. If the result is positive, a blood test is
needed to confirm the results.
H. Home test kits for HIV
. In one at-home test kit, a drop of
blood is placed on a test card with a
special code number; the card is
mailed to a laboratory for testing for
HIV antibodies.
. The individual receives the results by
calling a special telephone number and
entering the special code number; test
results are then given.
I. Nursing considerations
. Maintain issues of confidentiality
surrounding HIV and AIDS testing.
. Follow prescribed state regulations
and protocols related to reporting
positive tostresults.